{"id":"W3217773060","doi":"10.2217/nmt-2021-0042","title":"MN-166 (ibudilast) in Amyotrophic Lateral Sclerosis in a Phase IIb/III Study: COMBAT-ALS Study Design","year":2021,"lang":"en","type":"article","venue":"Neurodegenerative Disease Management","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre; Montreal Neurological Institute and Hospital","funders":"","keywords":"Amyotrophic lateral sclerosis; Tolerability; Medicine; Neuroprotection; Riluzole; Quality of life (healthcare); Placebo; Clinical trial; Context (archaeology); Disease; Pharmacology; Internal medicine; Oncology; Adverse effect; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004093941,0.002942078,0.003578546,0.0005350411,0.000628763,0.001460079,0.001044372,0.002262172,0.005043418],"category_scores_gemma":[0.001446008,0.0007984179,0.001322112,0.0005467169,0.001314747,0.0009111736,0.0005122815,0.002663313,0.001389157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007864274,"about_ca_system_score_gemma":0.002888404,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006523958,"about_ca_topic_score_gemma":0.001591153,"domain_scores_codex":[0.9989896,0.0005445376,0.00006296409,0.0001394639,0.00007765245,0.0001857088],"domain_scores_gemma":[0.9992878,0.00008950656,0.0001363706,0.00005705858,0.00008250026,0.0003466765],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.9370204,0.02652825,0.00147295,0.001041754,0.0007999506,0.0001232054,0.000106122,0.0005360497,0.01449716,0.0003604884,0.001926453,0.01558725],"study_design_scores_gemma":[0.8363891,0.1574554,0.001980447,0.00004197678,0.000461375,0.00004717745,0.00003192003,0.0003662839,0.0008279694,0.0002452112,0.002133053,0.0000200635],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"protocol","genre_scores_codex":[0.8970899,0.007692518,0.003789385,0.002092707,0.001000404,0.07715434,0.003246835,0.0003310092,0.007602869],"genre_scores_gemma":[0.8325346,0.006526085,0.01006773,0.005724092,0.001371506,0.1262871,0.003585663,0.0001166437,0.01378664],"genre_candidate":"protocol","genre_consensus":null,"teacher_disagreement_score":0.005043418,"threshold_uncertainty_score":0.02165109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08541449983593444,"score_gpt":0.3447099443251491,"score_spread":0.2592954444892147,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}